| 1 |
28577058 | Type B and A monoamine oxidase and their inhibitors regulate the gene expression of Bcl-2 and neurotrophic factors in human glioblastoma U118MG cells: different signal pathways for neuroprotection by selegiline and rasagiline. | 2017 Sep |
1 |
| 2 |
22892822 | ''70th Birthday Professor Riederer'' induction of glial cell line-derived and brain-derived neurotrophic factors by rasagiline and (-)deprenyl: a way to a disease-modifying therapy? | 2013 Jan |
1 |
| 3 |
23739004 | Revelation in the neuroprotective functions of rasagiline and selegiline: the induction of distinct genes by different mechanisms. | 2013 Jun |
1 |
| 4 |
20698822 | Monoamine oxidase inhibitors as neuroprotective agents in age-dependent neurodegenerative disorders. | 2010 |
1 |
| 5 |
19673610 | Functional mechanism of neuroprotection by inhibitors of type B monoamine oxidase in Parkinson's disease. | 2009 Aug |
1 |
| 6 |
17055733 | Activation of tyrosine kinase receptor signaling pathway by rasagiline facilitates neurorescue and restoration of nigrostriatal dopamine neurons in post-MPTP-induced parkinsonism. | 2007 Jan |
2 |
| 7 |
17982885 | Neuroprotection by propargylamines in Parkinson's disease: intracellular mechanism underlying the anti-apoptotic function and search for clinical markers. | 2007 |
1 |
| 8 |
18077571 | Induction of neurotrophic factors GDNF and BDNF associated with the mechanism of neurorescue action of rasagiline and ladostigil: new insights and implications for therapy. | 2007 Dec |
2 |
| 9 |
17447417 | Involvement of type A monoamine oxidase in neurodegeneration: regulation of mitochondrial signaling leading to cell death or neuroprotection. | 2006 |
1 |
| 10 |
14687604 | N-Propargyl-1 (R)-aminoindan, rasagiline, increases glial cell line-derived neurotrophic factor (GDNF) in neuroblastoma SH-SY5Y cells through activation of NF-kappaB transcription factor. | 2004 May |
3 |
| 11 |
12200198 | Neuroprotection by propargylamines in Parkinson's disease: suppression of apoptosis and induction of prosurvival genes. | 2002 Sep-Oct |
2 |